Improvement of skin inflammation and wound repair upon reduction of S100A9 by pharmacological inhibition or by reduction of SFA uncovers the pathogenic role of S100A9 overexpression in obesity. Here, S100A9 is linked to obesity due to melanocortin 4 receptor deficiency.